Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023
Thu, September 14, 2023
Wed, September 13, 2023
Tue, September 12, 2023

Paul Matteis Reiterated (ALNY) at Strong Buy and Held Target at $240 on, Sep 14th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-240-on-sep-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Paul Matteis of Stifel, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $240 on, Sep 14th, 2023.

Paul has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023


These are the ratings of the 4 analyists that currently disagree with Paul


  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Tuesday, September 12th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, August 7th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023